Principal Financial Group
KRTX

Principal Financial Group’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Principal Financial Group’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,910
Closed -$2.5M – 2522
2023
Q4 		$2.5M Sell
7,910
-977
-11% -$190K ﹤0.01% 1740
2023
Q3 		$1.5M Sell
8,887
-2,839
-24% -$534K ﹤0.01% 1796
2023
Q2 		$2.54M Buy
11,726
+811
+7% +$174K ﹤0.01% 1720
2023
Q1 		$1.98M Buy
10,915
+3
+0% +$574 ﹤0.01% 1763
2022
Q4 		$2.14M Buy
10,912
+3,089
+39% +$662K ﹤0.01% 1749
2022
Q3 		$1.76M Buy
7,823
+340
+5% +$68.8K ﹤0.01% 1739
2022
Q2 		$947K Buy
7,483
+21
+0.3% +$2.41K ﹤0.01% 1926
2022
Q1 		$946K Buy
7,462
+169
+2% +$19K ﹤0.01% 1982
2021
Q4 		$956K Sell
7,293
-2,883
-28% -$373K ﹤0.01% 1993
2021
Q3 		$1.25M Buy
10,176
+390
+4% +$45K ﹤0.01% 1958
2021
Q2 		$1.12M Buy
9,786
+503
+5% +$58.8K ﹤0.01% 2013
2021
Q1 		$1.12M Sell
9,283
-216
-2% -$24.5K ﹤0.01% 1969
2020
Q4 		$965K Buy
9,499
+4,118
+77% +$382K ﹤0.01% 1953
2020
Q3 		$416K Sell
5,381
-2,823
-34% -$241K ﹤0.01% 2050
2020
Q2 		$914K Buy
+8,204
New +$713K ﹤0.01% 1852

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Principal Financial Group's KRTX Position: Q1 2024 in Review

Principal Financial Group sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 7,910 shares — an estimated $2.5M sold.

Principal Financial Group first reported a position in KRTX in Q2 2020 and held it in 15 quarters. The position peaked at $2.54M in Q2 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Principal Financial Group reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Principal Financial Group sold 7,910 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.5M.
  • Principal Financial Group first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2020 and held it in 15 quarters.
  • Principal Financial Group's Karuna Therapeutics, Inc. Common Stock position peaked at $2.54M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Principal Financial Group's 13F filing for Q1 2024, filed 29 Apr 2024.